---
title: "United Therapeutics falls nearly 4% in regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306146946.md"
description: "United Therapeutics fell 3.95% to US$554.51. Down 6.54% over five sessions and up 13.80% YTD."
datetime: "2026-11-19T15:50:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306146946.md)
  - [en](https://longbridge.com/en/news/306146946.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306146946.md)
generator: "portal-rs"
---

# United Therapeutics falls nearly 4% in regular trading

United Therapeutics (UTHR.US) fell nearly **4%** during regular trading to **$554.51**.

The stock is down 6.54% over the past five sessions and up 13.80% year to date.

The Nasdaq Composite is down 3.70% over the past five sessions and up 5.10% year to date.

The biotechnology industry index fell 1.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports $5.51 Million Common Share Sale](https://longbridge.com/en/news/306020863.md)
- [United Therapeutics Corporation $UTHR Shares Purchased by AIA Group Ltd](https://longbridge.com/en/news/304413972.md)
- [United Therapeutics Corporation $UTHR Stock Sold by Nisa Investment Advisors LLC](https://longbridge.com/en/news/302964980.md)
- [Is United Therapeutics (UTHR) Undervalued On Earnings And Its $2b Buyback?](https://longbridge.com/en/news/304738402.md)
- [Why Is SoundHound AI (SOUN) Serving Nearly 8 Million Residents In Bogotá?](https://longbridge.com/en/news/306367933.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**